Register entry
BioConvergence LLC DBA Singota Solutions
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1Relabelling1Repackaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| BioConvergence LLC DBA Singota Solutions | 4320 West Zenith Drive, Bloomington, Indiana (IN) 47404, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging | 3005667192620582002 |
Neighbours
Registered in the same town
3- Bamboo US BidCo LLCBloomington, IN
- Cook IncorporatedBloomington, IN
- Catalent Indiana, LLCBloomington, IN
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is BioConvergence LLC DBA Singota Solutions FDA approved?
- BioConvergence LLC DBA Singota Solutions holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are BioConvergence LLC DBA Singota Solutions's drugs manufactured?
- The FDA register lists Bloomington, IN. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, relabelling, repackaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.